In a DDI study that included 27 subjects, our analyte was assessed with and without a co-administered drug for 0-120 h. The analyte was not detectable in any subject after 24 h and was detected in only 6–8 subjects at the 24-h time point and in 20 subjects at 12 h. All concentrations after 24 h through 120 h were BLOQ.
I am trying to fit the data to assess the GMR for AUCinf, but I am challenged by the fact that, for most subjects, the percentage of extrapolated AUC exceeds 20%. Can the algorithm in Phoenix impute values based on the observed terminal phase?
Please note that I have tried the imputation methods outlined in this paper. However, the methods described require at least some subjects to have observed values at these time points (24-120) to impute values for the other subjects.
The elimination half-life of our analyte typically ranges from 10 to 20 hours.